- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
Purpose Bitcoin ETF
Silver47 Exploration
Syntheia
CI Galaxy Bitcoin ETF
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Tweed Inc. (Tweed or the Company), a wholly-owned subsidiary of Canopy Growth Corporation (TSX:WEED) today announced that it has completed an intensive process of sourcing a diverse genetic seed bank and legally importing it into Canada. Tweed will begin selling cannabis seeds to authorized home growers under the Access to Cannabis for Medical Purposes Regulations in early March.
Tweed Inc., a wholly-owned subsidiary of Canopy Growth Corporation (TSX:WEED) today announced that it has completed an intensive process of sourcing a diverse genetic seed bank and legally importing it into Canada. Tweed will begin selling cannabis seeds to authorized home growers under the Access to Cannabis for Medical Purposes Regulations in early March.
Tweed has long supported patients’ right to grow their own cannabis and is proud to be able to support those who would prefer to grow their own medical supply. Tweed is only the second producer in Canada to offer a seed option and will also offer a wide variety of dried cannabis and cannabis oil products to authorized grow at home customers as a reliable interim supply during the months it takes home growers to produce their medicine. The Company will also offer seed customers will a one-time $25 discount that can be used towards the purchase of any Tweed cannabis product.
Kevin Furet, Tweed’s Master Grower and an award-winning breeder in his own right, curated a collection of genetics with lineages originating all around the world. The resulting Tweed HomeGrow Collection is made up of ten seed types designed to meet the diverse needs of patients.
“I was aiming for quality and diversity in this collection,” said Furet. “Medical cannabis patients have diverse needs so I wanted to create a collection that matched that diversity. I see ten options as a starting point that we can build on using our own cross breeding capabilities in our custom breeding area.”
The same seeds used in the HomeGrow collection will be grown out in Tweed’s breeding facility to produce proprietary genetics that can be sold as seed or as finished products. Announced late last year, the breeding area is a first in Canada and will allow Tweed to crossbreed existing genetics for all registered customers, including home growers.
Health Canada provides authorization for home production licenses. Interested individuals can visit the Health Canada website for more information on obtaining an authorization.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.